EMA publishes new GDP non-compliance report for wholesaler in Norway
Recommendation

17/18 June 2026
The European Database EudraGMDP doesn't only contain GMP, but also GDP reports of non-compliance. The Norwegian Authority has issued a statement of non-compliance with GDP for medicinal products of the company Norges NaturmedisinSentral AS, Terminalen 9, Bachetomta næringspark, Lierstranda industriområde, LIER, NO-3414, Norway.
The company was involved in the distribution of medicinal products requiring cold storage and transportation. These operations were not managed under GDP. As a consequence the WDA (Wholesale Distributor Authorisation) has been partly withdrawn. Cold chain activities are now no longer permitted.
Source: EudraGMDP Database (GDP Non-Compliance Report)
Related GMP News
12.05.2026European GDP Association Developments January through April 2026
12.05.2026How Are Service Providers Qualified in a GDP Environment?
12.05.2026Questions and Answers from the ECA Webinar "GDP Update 2026" - Part 3
11.05.2026European GDP Association Developments January through April 2026
21.04.2026Implementation of GDP for Pharmaceutical Products in Hong Kong
21.04.2026China's NMPA: Guiding Opinions & Q&A on Standardising Modern Pharmaceutical Logistics


